Barely Significant
← all excerpts

Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma.

Vaccines (Basel) · 2020 · PMC7563532 · PMID 32784389

1
hedged sentence
closest p
boldest claim

The sentences

sorafenib); however, the primary endpoint of OS did not reach statistical significance (HR, 0.85, 95% CI, 0.72–1.02).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.